Your session is about to expire
← Back to Search
Project Dulce + Dulce Digital for Type 2 Diabetes
N/A
Recruiting
Led By Emily Rose N. San Diego, PhD
Research Sponsored by Scripps Whittier Diabetes Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosed with T2DM
Be older than 18 years old
Must not have
Not willing to carry a mobile phone
Severe illness precluding frequent visits to clinic
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether a culturally adapted diabetes self-management program, delivered either in person or via text message, can improve diabetes knowledge and control in Filipino Americans with type 2 diabetes.
Who is the study for?
This trial is for Filipino-Americans with type 2 diabetes who can speak English and Tagalog, have an HbA1c level of ≥8%, and are registered or willing to register at a community clinic. It's not for those with severe illnesses, certain liver conditions, low body mass index, pregnancy, recent history of cancer (except some skin cancers), high creatinine levels, recent substance abuse issues, non-permanent residents in the area or current enrollees in Project Dulce.
What is being tested?
The study tests a culturally adapted diabetes self-management program called Project Dulce combined with a text messaging service named Dulce Digital. The goal is to improve diabetes knowledge and self-care among Filipino Americans by addressing cultural barriers. Effectiveness will be measured through changes in beliefs, attitudes towards diabetes management and hemoglobin A1C levels over 3 to 6 months.
What are the potential side effects?
Since this intervention involves education and digital communication rather than medication or invasive procedures, traditional side effects are not expected. However participants may experience discomfort from frequent monitoring of their health status.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with type 2 diabetes.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am not willing to carry a mobile phone.
Select...
I have a severe illness that prevents me from visiting the clinic often.
Select...
I have type 1 diabetes or had diabetes during pregnancy.
Select...
English or Tagalog is not my primary language.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from Baseline Diabetes Knowledge at 3 months
Change from Baseline Diabetes Knowledge at 6 months
Change from Baseline Health Belief Model Scale at 3 months
+3 moreSecondary study objectives
Change in Baseline Block Food Frequency Questionnaire at 3 months
Change in Baseline Block Food Frequency Questionnaire at 6 months
Change in Baseline Glycosylated Hemoglobin A1C (HbA1c) at 3 months; % Units
+5 moreOther study objectives
Participant Satisfaction
Recruitment and Retention
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Project Dulce + Dulce DigitalExperimental Treatment1 Intervention
Patients will participate in a peer-led group diabetes self-management education and support program and receive ongoing support via text messages designed to improve knowledge, health beliefs, self-management behaviors and clinical outcomes.
Find a Location
Who is running the clinical trial?
Scripps Whittier Diabetes InstituteLead Sponsor
18 Previous Clinical Trials
5,401 Total Patients Enrolled
3 Trials studying Diabetes
1,422 Patients Enrolled for Diabetes
National Center for Advancing Translational Sciences (NCATS)NIH
371 Previous Clinical Trials
412,868 Total Patients Enrolled
Emily Rose N. San Diego, PhDPrincipal InvestigatorScripps Whittier Diabetes Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your body mass index is less than or equal to 23.Your liver function tests show that your ALT and AST levels are more than three times higher than the normal range.I am not willing to carry a mobile phone.I have a severe illness that prevents me from visiting the clinic often.Your HbA1c level is higher than 8% within the last month.I have not donated blood or plasma recently.I have type 1 diabetes or had diabetes during pregnancy.English or Tagalog is not my primary language.Your creatinine level is higher than 3.5.You are currently participating in Project Dulce.I have anemia.I can speak, read, write, and understand both English and Tagalog.You are of Filipino descent and identify as Filipino.I have been cancer-free for more than 5 years, or I've only had skin cancer.I have been diagnosed with type 2 diabetes.
Research Study Groups:
This trial has the following groups:- Group 1: Project Dulce + Dulce Digital
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger